Antares Pharma (ATRS): Q2 EPS of -$0.03 in-line. Revenue of $4.5M (+28.6% Y/Y). (PR)


Antares Pharma (ATRS): Q2 EPS of -$0.03 in-line. Revenue of $4.5M (+28.6% Y/Y). (PR)
From other sites
Comments (2)
  • Mr_Maalox
    , contributor
    Comment (1) | Send Message
     
    Love this stock.............
    8 Aug 2012, 08:03 AM Reply Like
  • cusafr1989
    , contributor
    Comments (2) | Send Message
     
    So, is this good, bad, or neutral news?
    8 Aug 2012, 11:20 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs